The Regulation of Biologics and Biosimilars: An Introduction
Understand differences between biologics and small molecule drugs and effect on regulating generic drugs and biosimilars. Learn regulatory standards for biosimilars and interchangeable biosimilars. Discuss the regulatory exclusivities available for biologics. Address the differences between switching and substitution. Explore the Patent Dance.
Jacqueline R. Berman, Partner, Morgan, Lewis & Bockius LLP
This session was recorded as part of FDLI’s Introduction to Drug Law and Regulation Course in November 2022.
- +$100 for nonmembers
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.
Virtual Learning FAQ